{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = 
| image = 
| width = 

<!--Clinical data-->
| tradename = Fiblast
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration = [[Topical medication|Topical]] ([[Spray (liquid drop)|spray]])<ref name="Han2015" />

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!-- Identifiers -->
| CAS_number_Ref = 
| CAS_number = 131094-16-1
| CAS_supplemental = 
| class = 
| ATC_prefix = 
| ATC_suffix = 
| ATC_supplemental = 
| PubChemSubstance = 17397511
| IUPHAR_ligand = 
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = none
| UNII = 333OX80X87
| KEGG = D03362
| ChEBI = 
| ChEMBL = 

<!--Chemical data-->
| C=764 | H=1201 | N=217 | O=219 | S=6
| molecular_weight = 17122.4232 g/mol
| SMILES = 
| StdInChI_Ref = 
| StdInChI = 
| StdInChIKey_Ref = 
| StdInChIKey = 
| synonyms = CAB-2001; Recombinant human basic fibroblast growth factor; rhbFGF; 2-155-Basic fibroblast growth factor (human clone lambdaKB7/lambdaHFL1 precursor reduced)
}}

'''Trafermin''' (brand name '''Fiblast'''), also known as '''recombinant human basic fibroblast growth factor''' ('''rhbFGF'''), is a [[recombinant protein|recombinant]] form of human [[basic fibroblast growth factor]] (bFGF) which is marketed in [[Japan]] as a [[topical medication|topical]] [[Spray (liquid drop)|spray]] for the treatment of [[skin ulcer]]s.<ref name="AdisInsight">http://adisinsight.springer.com/drugs/800009962</ref><ref name="Drugs.com">https://www.drugs.com/international/trafermin.html</ref><ref name="Han2015">{{cite book|author=Seung-Kyu Han|title=Innovations and Advances in Wound Healing|url=https://books.google.com/books?id=IY-QCgAAQBAJ&pg=PA206|date=15 September 2015|publisher=Springer|isbn=978-3-662-46587-5|pages=206–}}</ref> It is also currently in preregistration for the treatment of [[periodontitis]].<ref name="AdisInsight" /><ref name="pmid26547659">{{cite journal | vauthors = Kitamura M, Akamatsu M, Kawanami M, Furuichi Y, Fujii T, Mori M, Kunimatsu K, Shimauchi H, Ogata Y, Yamamoto M, Nakagawa T, Sato S, Ito K, Ogasawara T, Izumi Y, Gomi K, Yamazaki K, Yoshie H, Fukuda M, Noguchi T, Takashiba S, Kurihara H, Nagata T, Hamachi T, Maeda K, Yokota M, Sakagami R, Hara Y, Noguchi K, Furuuchi T, Sasano T, Imai E, Ohmae M, Koizumi H, Watanuki M, Murakami S | title = Randomized Placebo-Controlled and Controlled Non-Inferiority Phase III Trials Comparing Trafermin, a Recombinant Human Fibroblast Growth Factor 2, and Enamel Matrix Derivative in Periodontal Regeneration in Intrabony Defects | journal = J. Bone Miner. Res. | volume = 31 | issue = 4 | pages = 806–14 | year = 2016 | pmid = 26547659 | doi = 10.1002/jbmr.2738 | url = }}</ref> As a recombinant form of bFGF, trafermin is a [[potency (pharmacology)|potent]] [[agonist]] of the [[Fibroblast growth factor receptor 1|FGFR1]], [[Fibroblast growth factor receptor 2|FGFR2]], [[Fibroblast growth factor receptor 3|FGFR3]], and [[Fibroblast growth factor receptor 4|FGFR4]].<ref name="BarrettGhishan2006">{{cite book |author1= Kim E. Barrett |author2= Fayez K. Ghishan |author3= Juanita L. Merchant |author4= Hamid M. Said, Jackie D. Wood |title= Physiology of the Gastrointestinal Tract |url= https://books.google.com/books?id=CNwLlih2C60C&pg=PA216 |date=10 May 2006 |publisher= Academic Press |isbn= 978-0-08-045615-7 |pages=216–}}</ref><ref name="Said2012">{{cite book|author=Hamid M. Said|title=Physiology of the Gastrointestinal Tract, Two Volume Set|url=https://books.google.com/books?id=ytWBLAy1FGQC&pg=PA235|date=4 July 2012|publisher=Academic Press|isbn=978-0-12-382027-3|pages=235–}}</ref> The drug has been marketed in Japan since June 2001.<ref name="Spaccapelo">Spaccapelo, L. RATIONALE FOR BASIC FGF IN WOUND HEALING AND REVIEW OF THERAPEUTIC APPLICATIONS.</ref>

==References==
{{Reflist|2}}

==External links==
* [http://adisinsight.springer.com/drugs/800009962 Trafermin - AdisInsight]


{{Preparations for treatment of wounds and ulcers}}
{{Growth factor receptor modulators}}

[[Category:Growth factors]]
[[Category:Human proteins]]
[[Category:Recombinant proteins]]


{{protein-stub}}
{{dermatologic-drug-stub}}